Logo image
The Endocrine Role of Bone in Cardiometabolic Health
Journal article   Open access   Peer reviewed

The Endocrine Role of Bone in Cardiometabolic Health

Rosemary DeLuccia, May Cheung, Rohit Ramadoss, Abeer Aljahdali and Deeptha Sukumar
Current nutrition reports, v 8(3)
01 Sep 2019
PMID: 31297756
url
https://doi.org/10.1007/s13668-019-00286-0View
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze) Open

Abstract

Life Sciences & Biomedicine Nutrition & Dietetics Science & Technology
Purpose of Review The purpose of this review is to discuss the current knowledge about major bone regulating hormones vitamin D, parathyroid hormone (PTH), estrogen and bone metabolism markers osteocalcin (OC), bone-specific alkaline phosphatase (BAP), N-terminal propeptide of type 1 collagen (P1NP), and c-terminal type 1 collagen (CTX) and their mechanistic effects on cardiometabolic health. Recent Findings Bone regulating hormones, nutrients, and turnover markers influence different aspects of cardiometabolic health including body composition, cardiovascular function, and glycemic control. While most observational research supports a relationship between bone as an endocrine organ and cardiometabolic outcomes, there are limited human clinical trials to strengthen a causal link between the two. Summary While the associations between bone and cardiometabolic health are beginning to be understood based on findings from large observations studies, further exploration of bone's causal influence on health outcomes in humans and the underlying mechanisms of effect are necessary.

Metrics

13 Record Views
13 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Nutrition & Dietetics
Logo image